<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03173326</url>
  </required_header>
  <id_info>
    <org_study_id>170741</org_study_id>
    <nct_id>NCT03173326</nct_id>
  </id_info>
  <brief_title>Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy</brief_title>
  <official_title>Randomized Controlled Trial Evaluating Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the efficacy of two different anesthetic techniques in patients
      undergoing unilateral knee arthroscopy. Participants will be randomized to receive either
      subarachnoid block with 2-chloroprocaine or general anesthesia plus intravenous fentanyl.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study evaluates the efficacy of two different anesthetic techniques in patients
      undergoing unilateral knee arthroscopy. Participants will be randomized to receive either
      subarachnoid block with 2-chloroprocaine or general anesthesia plus intravenous fentanyl. The
      study evaluates pain scores, opioid utilization and patient satisfaction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 16, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>Discharge from post anesthesia care unit (PACU) (usually one hour)</time_frame>
    <description>Pain score measured with a patient reported 11 point Numeric Rating Pain Scale with 0 indicating no pain and 10 indicating worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>Post operative day one</time_frame>
    <description>Pain score measured with a patient reported 11 point Numeric Rating Pain Scale with 0 indicating no pain and 10 indicating worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>One month postoperatively</time_frame>
    <description>Pain score measured with a patient reported 11 point Numeric Rating Pain Scale with 0 indicating no pain and 10 indicating worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>Three months postoperatively</time_frame>
    <description>Pain score measured with a patient reported 11 point Numeric Rating Pain Scale with 0 indicating no pain and 10 indicating worst pain imaginable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid utilization</measure>
    <time_frame>Surgical completion to PACU discharge (usually one hour)</time_frame>
    <description>Opioid utilization based on amount of opioid medications administered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid utilization</measure>
    <time_frame>Postoperative day one</time_frame>
    <description>Opioid utilization based on number of pain pills taken</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid utilization</measure>
    <time_frame>One month postoperatively</time_frame>
    <description>Opioid utilization based on average number of pain pills taken per day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid utilization</measure>
    <time_frame>Three months postoperatively</time_frame>
    <description>Opioid utilization based on average number of pain pills taken per day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with anesthetic</measure>
    <time_frame>24 hours after PACU discharge</time_frame>
    <description>Patient satisfaction with anesthetic based on 10-item patient satisfaction survey validated for regional and general anesthesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Knee Arthroscopy</condition>
  <condition>General Anesthesia</condition>
  <condition>Subarachnoid Block</condition>
  <arm_group>
    <arm_group_label>Subarachnoid block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <description>General anesthesia will be delivered per standard procedure. General anesthesia will include induction with propofol 1-3mg/kg followed by placement of a laryngeal mask airway with maintenance anesthesia of sevoflurane 0.5-1 minimum alveolar concentration (MAC).</description>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subarachnoid block</intervention_name>
    <description>Neuraxial anesthesia will be performed at the L2-3 or L3-4 interspace with a 25-gauge Whitacre needle in the sitting position. After free flow of cerebrospinal fluid (CSF), 40-45mg of 2-chloroprocaine will be injected based on patient's height and discretion of attending anesthesiologist, needle withdrawn and the patient placed supine.</description>
    <arm_group_label>Subarachnoid block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ASA physical status classification of I, II, or III

          -  Patients without a current diagnosis of chronic pain or chronic opioid use for &gt;
             1-month prior to knee arthroscopy

          -  Patients who are scheduled to undergo unilateral knee arthroscopy

          -  Patients do not have a contraindication to receiving regional anesthesia

        Exclusion Criteria:

          -  Preexisting sensory or motor deficit in operative extremity

          -  Patients with a contraindication to general anesthesia

          -  Patient undergoing meniscal or ligamentous repair
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jenna Walters, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jenna Walters, M.D.</last_name>
    <phone>615-936-3198</phone>
    <email>jenna.l.walters@vanderbilt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gail Mayo, RN</last_name>
    <phone>615-936-1705</phone>
    <email>gail.mayo@vanderbilt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenna Walters, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2017</study_first_submitted>
  <study_first_submitted_qc>May 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>June 21, 2017</last_update_submitted>
  <last_update_submitted_qc>June 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Jenna Walters</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Chloroprocaine</mesh_term>
    <mesh_term>Procaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

